Viewing data from:

NYSTATIN

ANDA

NYSTATIN | A211838 | TORRENT PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.2537

per gm

Lowest NADAC/Unit

$0.2435

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
13668053401NYSTATIN 100,000 UNIT/GM OINT	$0.2537	GM	Generic	—	2026-06-17
13668053402NYSTATIN 100,000 UNIT/GM OINT	$0.2435	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs5 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

CENTRIENT PHARMACEUTICALS NETHERLANDS BVNYSTATIN

DMF 135231998

VUAB PHARMA ASNYSTATIN USP

DMF 140561999

ANTIBIOTICE SANYSTATIN

DMF 148132000

CONCORD BIOTECH LTDNYSTATIN USP

DMF 417912025

SHAOXING PHARMACEUTICAL FACTORYInactiveNYSTATIN

DMF 125571997

ER SQUIBB AND SONS INCInactiveNYSTATIN

DMF 132981998

BRISTOL MYERS SQUIBB COInactiveNYSTATIN

DMF 134411998

LEDERLE LABORATORIESInactiveNYSTATIN BULK POWDER

DMF 150282000

OLON SPAInactiveNYSTATIN

DMF 352252020

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 100,000 UNITS/GM

0 patents0 exclusivities▴

OINTMENT;TOPICAL | Approved: Jan 28, 2019

No patent or exclusivity listings for this strength.